BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 27889552)

  • 1. Relation of red blood cell distribution width with CHADS
    Liu T; Shao Q; Korantzopoulos P; Miao S; Zhang Z; Xu G; Yuan R; Li G
    Int J Cardiol; 2017 Feb; 228():861-864. PubMed ID: 27889552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of red cell distribution width with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation.
    Kurt M; Tanboga IH; Buyukkaya E; Karakas MF; Akçay AB; Sen N
    Clin Appl Thromb Hemost; 2014 Oct; 20(7):687-92. PubMed ID: 23430929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red Cell Distribution Width with CHADS2 and CHA2DS2-VASc score is associated with Post-operative Atrial Fibrillation after Coronary Artery Bypass Grafting.
    Kılıcgedik A; Naser A; Gurbuz AS; Kulahcioglu S; Bakal RB; Unkun T; Yilmaz F; Kahveci G; Kirma C
    Heart Surg Forum; 2018 May; 21(3):E170-E174. PubMed ID: 29893674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between big endothelin-1 and CHADS
    Zheng LH; Liu SY; Hu F; Liang EP; Wu LM; Wang HL; Killu AM; Yao Y
    J Geriatr Cardiol; 2019 Nov; 16(11):812-817. PubMed ID: 31853246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
    Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
    Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of Predictive Value for Thromboembolic Risk by Incorporating Left Atrial Functional Parameters in the CHADS2 and CHA2DS2-VASc Scores.
    Kim MN; Kim SA; Choi JI; Park SM; Park SW; Kim YH; Shim WJ
    Int Heart J; 2015 May; 56(3):286-92. PubMed ID: 25912904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive role of CHADS2 and CHA2DS2-VASc scores on stroke and thromboembolism in patients without atrial fibrillation: a meta-analysis.
    Liu FD; Shen XL; Zhao R; Li GF; Wu YL; Tao XX; Wang S; Zhou JJ; Zheng B; Zhang QT; Yao Q; Zhao Y; Zhang X; Wang XM; Liu HQ; Shu L; Liu JR
    Ann Med; 2016 Aug; 48(5):367-75. PubMed ID: 27153002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
    Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial spontaneous echo contrast occurring in patients with low CHADS
    Akamatsu K; Ito T; Ozeki M; Miyamura M; Sohmiya K; Hoshiga M
    Cardiovasc Ultrasound; 2020 Aug; 18(1):31. PubMed ID: 32738924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CHADS
    Barkas F; Elisaf M; Korantzopoulos P; Tsiara S; Liberopoulos E
    Int J Cardiol; 2017 Aug; 241():194-199. PubMed ID: 28442233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the CHADS2 and CHA 2DS 2-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients.
    Hrynkiewicz-Szymanska A; Dluzniewski M; Platek AE; Szymanski FM; Syska-Suminska J; Klos-Szadryn A; Glinka M; Strojek M; Kuciej A; Tomaszewska-Kiecana M
    J Thromb Thrombolysis; 2015 Aug; 40(2):240-7. PubMed ID: 25490871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
    Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Value of the CHADS
    Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation: Utility of CHADS
    Lahewala S; Arora S; Patel P; Kumar V; Patel N; Tripathi B; Patel N; Kallur KR; Shah H; Syed A; Gidwani U; Viles-Gonzalez JF; Deshmukh A
    Int J Cardiol; 2017 Oct; 245():162-167. PubMed ID: 28874288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.